Intracellular signaling proteins and transcription factors

Intracellular signaling proteins and transcription factors represent a broad functional category of proteins rather than a single therapeutic target. This group includes kinases, phosphatases, and GTPases that propagate extracellular signals through the cytoplasm, as well as transcription factors that ultimately modulate gene expression in the nucleus (NCBI, 2023; Nature Education, 2014). These molecules are critical for maintaining cellular homeostasis, and their dysregulation is a primary driver of oncogenesis, inflammatory disorders, and metabolic diseases (PubMed, 2022). While individual members of this class, such as the Janus kinases (JAKs) or Estrogen Receptors, are well-validated drug targets, the category as a whole is too diverse for a single therapeutic approach (DrugBank, 2024). Drugs targeting these proteins typically function as small-molecule inhibitors, antagonists, or degraders like PROTACs, aiming to restore normal signaling or block pathological gene transcription (StatPearls, 2023). Because these proteins often participate in multiple, overlapping pathways, therapeutic intervention requires high specificity to avoid significant systemic toxicity and off-target effects (UniProt, 2024).

Other names

Signal transducersTranscription regulatorsIntracellular signaling moleculesSignal transduction proteinsSignal transduction pathways

Inhibition of enzymatic activity (e.g., kinase inhibition), modulation of nuclear receptor activity, disruption of protein-protein or protein-DNA interactions, and targeted protein degradation.